NEW YORK, June 13, 2022 /PRNewswire/ -- As per Zion Market Research study,
The global epilepsy therapeutics market was valued at over $13 billion in 2021 and is likely to surpass $18.1 billion by the end of 2028. The market is expected to expand at a considerable CAGR of 3.5% during the forecast period.
Key Industry Insights & Finding of the Epilepsy Therapeutics Market Reports:
As per the analysis shared by our research analyst, the Epilepsy Therapeutics Market is expected to grow annually at a CAGR of around
3.5 % (2022-2028).
Through the primary research, it was established that the Epilepsy Therapeutics Market was valued approximately
USD
13 Billion in 2021 and is projected to reach to roughly
USD
18.1 Billion by 2028.
This is majorly due to higher investments in R&D, increasing awareness and availability of advanced Epilepsy Therapeutics drugs in North America region.
Asia Pacific is witnessing a significant growth in the global Epilepsy Therapeutics market over the upcoming years. Due government initiatives in the field, Increased awareness and technological advancement in field is fueling the growth of global Epilepsy Therapeutics market.
Zion Market Research published the latest report titled as
"Epilepsy Therapeutics Market By Drugs (First Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Generation Anti-Epileptics), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others), By Location (Rural And Urban), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data And Forecasts 2022 – 2028." into their research database.
Epilepsy Therapeutics Market: Overview
Epilepsy Therapeutics refers to chronic neurological disorder which causes constant and unfounded seizures. An individual suffering from Epilepsy Therapeutics tends to have seizures with no explanation. In Epilepsy Therapeutics, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. The increase in the number of accidents and brain injuries and the high rate of post-traumatic Epilepsy Therapeutics (PTE) and post-traumatic seizure (PTS) occurrence in patients with brain injuries are the major factors driving the Epilepsy Therapeutics treatment market.
Furthermore, innovation of new treatment products with better efficiency is expected to further drive this market. Rising number of mergers and acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest trends that have been observed in the global Epilepsy Therapeutics market. Besides development of new drugs and treatment options, approval and launch of new products extend profitable opportunities to the Epilepsy Therapeutics treatment market players in the forecast period.
In Addition, development of highly efficacious products, having less side-effects, and better outcomes are likely to propel the Epilepsy Therapeutics market Neurological disorders have become a matter of concern for medical researchers who are looking at optimizing medical treatments. Furthermore, the adoption of anti-epileptics due to increasing seizures and Epilepsy Therapeutics cases, and a rise in research and development is driving the growth of Epilepsy Therapeutics market. .However, factors such as lack of awareness about the condition some developing regions and reluctance to adopt Epilepsy Therapeutics medications in some regions are restraining the growth of the Epilepsy Therapeutics market over the upcoming years.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis):
Our Free Sample Report Includes:
2022 Updated Report Introduction, Overview, and In-depth industry analysis
COVID-19 Pandemic Outbreak Impact Analysis Included
172 + Pages Research Report (Inclusion of Updated Research)
Provide Chapter-wise guidance on Request
2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes Updated List of tables & figures
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
Zion Market Research methodology
Industry Dynamics:
Epilepsy Therapeutics Market: Growth Drivers
Active Government Support and Investments to Expedite Market Growth.
Governmental initiatives to improve the healthcare sectors and higher investments in R&D is anticipated to expand at a notable growth of Epilepsy Therapeutics market during the forecast period. Rise in the number of approvals by government bodies is providing beneficial for the patients in controlling the seizures. This is projected to fuel the adoption of anticonvulsant and boost the market growth over the upcoming years.
Epilepsy Therapeutics Market: Restraints
Epilepsy Medicine shortage to hamper the market growth.
One of the major factors restraining the growth of Epilepsy Therapeutics market during the forecast period is steep rise in medicine shortage. Patients are stockpiling these medicines as there is a shortage of drugs in pharmacies which has raised an alarm in investigating the medicine supply chain globally. This is ultimately affecting the global Epilepsy Therapeutics market as the market becomes less desirable for Epilepsy Therapeutics medications.
Directly Purchase a Copy of the Report @
Global Epilepsy Therapeutics Market: Segmentation
The global Epilepsy Therapeutics market is segregated based on Product, distribution channel, end-user, and region.
Based on distributional channel, the global Epilepsy Therapeutics market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is projected to dominate the global market. growing number of hospitals, along with adequate reimbursement policies provided by these settings, are some of the major factors responsible for higher growth of hospital pharmacy over the upcoming years. This is eventually responsible for the adoption of antiepileptic drugs by the hospital pharmacies globally.
Based on product market has been classified into first generation Epilepsy Therapeutic second-generation Epilepsy Therapeutics and third generation Epilepsy Therapeutics. The second-generation epilepsy therapeutics segment is expected to hold a significant share of the global epilepsy therapeutics. This is due to increased penetration in the market and better effectiveness as compared to first generation Epilepsy Therapeutics.
Get More Insight before [email protected] :
List of Key Players of Epilepsy Therapeutics Market:
BIAL - PORTELA & CA SA
GlaxoSmithKline Plc
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
SanofiSA
Sunovion Pharmaceuticals Inc.
UCB SA
Zogenix Inc.
Key questions answered in this report:
What are the growth rate forecast and market size for Epilepsy Therapeutics Market?
What are the key driving factors propelling the Epilepsy Therapeutics Market forward?
What are the most important companies in the Epilepsy Therapeutics Market Industry?
What segments does the Epilepsy Therapeutics Market cover?
How can I receive a free copy of the Epilepsy Therapeutics Market sample report and company profiles?
Report Scope:
Free Brochure:
Recent Developments:
In January 2020, Eisai Co. Announced the launch of FYCOMPA in China for the treatment of partial-onset seizures in patients aged 12 years and older.
Regional Dominance:
Increasing awareness and availability.
North America dominates the global market for Epilepsy Therapeutics during the forecast period. This is majorly due to higher investments in R&D, increasing awareness and availability of advanced Epilepsy Therapeutics drugs in this region. Moreover, improved healthcare facilities are driving the market for Epilepsy Therapeutics in North America during the forecast period.
Asia Pacific is witnessing a significant growth in the global Epilepsy Therapeutics market over the upcoming years. Due government initiatives in the field, Increased awareness and technological advancement in field is fueling the growth of global Epilepsy Therapeutics market.
Global Epilepsy Therapeutics Market is segmented as follows:
Epilepsy Therapeutics Market: By Types Covered Outlook (2022-2028)
Anti-Epileptic Drugs
Brain Surgery
Dietary Supplements
Ketogenic Diet
Surgical Therapies
Epilepsy Therapeutics Market: By End Users Covered Outlook (2022-2028)
Ambulatory Surgical Centers
Hospitals& Clinics
Home Care Settings
Neurology Centers
Epilepsy Therapeutics Market: By Products Covered Outlook (2022-2028)
First Generation Epilepsy Therapeutics
Second Generation Epilepsy Therapeutics
Third Generation Epilepsy Therapeutics
Epilepsy Therapeutics Market: By Distribution Channels Covered Outlook (2022-2028)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy-User
Epilepsy Therapeutics Market: By Region Outlook (2022-2028)
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Press Release For Epilepsy Therapeutics Market:
Browse Other Related Research Reports from Zion Market Research
Cannabis Cultivation Market - Global Industry Analysis
: The global Cannabis Cultivation Market accrued earnings worth approximately 147.3 (USD Billion) in 2020 and is predicted to gain revenue of about 359.6 (USD Billion) by 2028, is set to record a CAGR of nearly 14.5% over the period from 2021 to 2028.
Pharmaceutical Sterility Testing Market - Global Industry Analysis
: The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028.
Respiratory Disorders Treatment Market - Global Industry Analysis
: The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the
Global Pharmaceutical Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us
.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Website:
Blog -
SOURCE Zion Market Research
